Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...

Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...

Researchers at the University of California San Diego have found an unusual ally in the quest to make cancer diagnosis faster ...

Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.

The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...

Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today published its Annual Report 2024. Philips' Annual Report 2024 will be on the agenda of the Annual General ...